Description
BSE announces the upcoming listing and admission to trading of equity shares of Nephrocare Health Services Limited with scrip code 544647 and symbol NEPHROPLUS.
Summary
BSE has announced that equity shares of Nephrocare Health Services Limited will be listed and admitted to dealings on the Exchange in due course. The company has been assigned scrip code 544647, symbol NEPHROPLUS, and ISIN number INE428V01029. The specific date of listing and detailed security information will be communicated through a separate notice.
Key Points
- Company Name: Nephrocare Health Services Limited
- Scrip Code: 544647
- Trading Symbol: NEPHROPLUS
- ISIN Number: INE428V01029
- Listing status: Approved, awaiting specific date announcement
- Segment: Equity
Regulatory Changes
No regulatory changes associated with this circular. This is a standard listing announcement.
Compliance Requirements
Trading members of the Exchange are informed to note the new listing. No specific compliance actions required at this stage pending the formal listing date announcement.
Important Dates
- Notice Date: December 16, 2025
- Listing Date: To be announced through separate notice
Impact Assessment
This is a routine new listing announcement with minimal immediate market impact. Trading members should be aware of the upcoming addition to the equity segment. The actual market impact will depend on the company’s size, sector, and trading activity once listing commences. Further details regarding the securities and official listing date are awaited.
Impact Justification
Standard new listing announcement for a single company with no immediate market impact; listing date to be announced separately.